Ferrer inCode SL-Product Pipeline Analysis, 2017 Update

Ferrer inCode SL-Product Pipeline Analysis, 2017 Update

  • Products Id :- GDME172910PD
  • |
  • Pages: 22
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary


Ferrer inCode SL (Ferrer), a subsidiary of Grupo Ferrer Internacional SA is a provider of molecular diagnostics and personalized medicine solutions. The company offers biotechnological solutions to make clinical decisions for patients. Its products comprise microarray-based gene expression test, multigene profile, prognosis and predictive tool, expression panel, diagnostic tools and others. Ferrer promotes and grants access to personalized medicine through prognosis, diagnosis, and prediction based in genomics, proteomics, metabolomics, and bioinformatics technology. The company offers treatment for oncological, cardiovascular and CNS diseases. Ferrer is headquartered in Barcelona, Spain.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Ferrer inCode SL

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Ferrer inCode SL Company Overview 4

Ferrer inCode SL Company Snapshot 4

Ferrer inCode SL Pipeline Products and Ongoing Clinical Trials Overview 4

Ferrer inCode SL-Pipeline Analysis Overview 7

Ferrer inCode SL-Key Facts 7

Ferrer inCode SL-Major Products and Services 8

Ferrer inCode SL Pipeline Products by Development Stage 9

Ferrer inCode SL Pipeline Products Overview 11

DAP 11

DAP Product Overview 11

FAB-118 12

FAB-118 Product Overview 12

StrokeChip 13

StrokeChip Product Overview 13

VHC-Core 14

VHC-Core Product Overview 14

Ferrer inCode SL-Key Competitors 15

Ferrer inCode SL-Key Employees 16

Ferrer inCode SL-Locations And Subsidiaries 17

Head Office 17

Recent Developments 18

Ferrer inCode SL, Recent Developments 18

Aug 27, 2016: The first epigenetic test to identify tumors of unknown primary 18

Appendix 19

Methodology 19

About GlobalData 21

Contact Us 21

Disclaimer 21

List of Figures

Ferrer inCode SL Pipeline Products by Equipment Type 5

Ferrer inCode SL Pipeline Products by Development Stage 9

List of Tables

Ferrer inCode SL Pipeline Products and Ongoing Clinical Trials Overview 4

Ferrer inCode SL Pipeline Products by Equipment Type 5

Ferrer inCode SL Pipeline Products by Indication 6

Ferrer inCode SL, Key Facts 7

Ferrer inCode SL, Major Products and Services 8

Ferrer inCode SL Number of Pipeline Products by Development Stage 9

Ferrer inCode SL Pipeline Products Summary by Development Stage 10

DAP-Product Status 11

DAP-Product Description 11

FAB-118-Product Status 12

FAB-118-Product Description 12

StrokeChip-Product Status 13

StrokeChip-Product Description 13

VHC-Core-Product Status 14

VHC-Core-Product Description 14

Ferrer inCode SL, Key Employees 16

Glossary 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

Ferrer inCode SL, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 52500
Site License
USD 1500 INR 105000
Corporate User License
USD 2250 INR 157500



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com